Danyelza Injection, Form : Liquid

₹ 67,000 - ₹ 90,000 / box

FormLiquid
CompositionNaxitamab
Strength40 mg
Number Of FlowerAllopathic
Supply TypeExporter, Supplier
Preferred Buyer Location All Countries Except India

Company Information

4.0/5

Member Since 1 Year
Nature of Business Manufacturer
Year of Establishment 2020

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Strength40 mg
FormLiquid
Number Of FlowerAllopathic
Country of OriginUSA
CompositionNaxitamab
StorageCool & Dry Place
Generic NameDanyelza

Danyelza is used, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat pediatric patients aged 1 year and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have a partial response, minor response, or stable disease to prior therapy.

Interested in this product? Ask for more details & Latest Price from seller

Share your requirements for a quick response!